Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Colorcon
Accenture
AstraZeneca
Farmers Insurance
QuintilesIMS
Fish and Richardson
Express Scripts
Cerilliant
Chubb

Generated: April 23, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 020478

« Back to Dashboard

NDA 020478 describes ULTANE, which is a drug marketed by Abbvie and is included in one NDA. It is available from one supplier. There is one patent protecting this drug. Additional details are available on the ULTANE profile page.

The generic ingredient in ULTANE is sevoflurane. There are five drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the sevoflurane profile page.
Summary for 020478
Tradename:ULTANE
Applicant:Abbvie
Ingredient:sevoflurane
Patents:1
Formulation / Manufacturing:see details
Pharmacology for NDA: 020478
Physiological EffectGeneral Anesthesia
Suppliers and Packaging for NDA: 020478
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
ULTANE sevoflurane LIQUID;INHALATION 020478 NDA AbbVie Inc. 0074-4456 N 0074-4456-04
ULTANE sevoflurane LIQUID;INHALATION 020478 NDA AbbVie Inc. 0074-4456 N 0074-4456-51

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:LIQUID;INHALATIONStrength100%
Approval Date:Jun 7, 1995TE:ANRLD:Yes
Patent:➤ Try a Free TrialPatent Expiration:Jul 9, 2018Product Flag?Substance Flag?Delist Request?Y

Expired US Patents for NDA 020478

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Abbvie ULTANE sevoflurane LIQUID;INHALATION 020478-001 Jun 7, 1995 ➤ Try a Free Trial ➤ Try a Free Trial
Abbvie ULTANE sevoflurane LIQUID;INHALATION 020478-001 Jun 7, 1995 ➤ Try a Free Trial ➤ Try a Free Trial
Abbvie ULTANE sevoflurane LIQUID;INHALATION 020478-001 Jun 7, 1995 ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Federal Trade Commission
Dow
Moodys
Argus Health
Julphar
Medtronic
McKinsey
Fish and Richardson
Queensland Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.